🔗 Share this article

The top legal official in Texas Ken Paxton is suing the makers of Tylenol, alleging the firms concealed potential risks that the drug presented to children's brain development.

The court filing comes a month after Former President Trump promoted an unsubstantiated connection between using Tylenol - alternatively called paracetamol - while pregnant and autism spectrum disorder in children.

Paxton is suing the pharmaceutical giant, which previously sold the drug, the exclusive pain medication suggested for pregnant women, and Kenvue, which presently makes it.

In a official comment, he said they "deceived the public by making money from pain and pushing pills regardless of the dangers."

The company says there is insufficient reliable data connecting Tylenol to autism spectrum disorder.

"These manufacturers misled for generations, knowingly endangering numerous people to boost earnings," the attorney general, a Republican, said.

The manufacturer said in a statement that it was "seriously troubled by the dissemination of inaccurate information on the reliability of paracetamol and the possible consequences that could have on the welfare of women and children in America."

On its online platform, Kenvue also said it had "continuously evaluated the relevant science and there is insufficient valid information that shows a verified association between using paracetamol and autism spectrum disorder."

Associations acting on behalf of doctors and health professionals agree.

The leading OB-GYN organization has declared paracetamol - the key substance in Tylenol - is one of the few options for pregnant women to address discomfort and elevated temperature, which can create significant medical dangers if not addressed.

"In more than two decades of research on the consumption of paracetamol in pregnancy, not a single reputable study has successfully concluded that the consumption of paracetamol in any stage of gestation leads to neurological conditions in offspring," the association commented.

This legal action mentions recent announcements from the former administration in arguing the drug is potentially dangerous.

Recently, Trump generated worry from health experts when he advised pregnant women to "fight like hell" not to use Tylenol when unwell.

Federal regulators then published an announcement that doctors should consider limiting the use of Tylenol, while also stating that "a direct connection" between the medication and autism spectrum disorder in young ones has not been proven.

Health Secretary Kennedy, who manages the Food and Drug Administration, had promised in April to initiate "a massive testing and research effort" that would determine the cause of autism in a limited time.

But specialists cautioned that discovering a single cause of autism - considered by experts to be the outcome of a complex mix of inherited and surrounding conditions - would be difficult.

Autism is a category of permanent neurological difference and condition that influences how persons encounter and relate to the environment, and is diagnosed using physician assessments.

In his lawsuit, the attorney general - a Trump ally who is seeking the Senate - asserts Kenvue and Johnson & Johnson "intentionally overlooked and tried to quiet the evidence" around paracetamol and autism.

The case attempts to require the corporations "destroy any commercial messaging" that states acetaminophen is secure for pregnant women.

The Texas lawsuit echoes the concerns of a assembly of guardians of children with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the makers of acetaminophen in 2022.

The court dismissed the legal action, saying studies from the family's specialists was not conclusive.